| 000 | 01547 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250514203754.0 | ||
| 264 | 0 | _c20050408 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a0090-9556 | ||
| 024 | 7 |
_a10.1124/dmd.104.001743 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHirani, Vandana N | |
| 245 | 0 | 0 |
_aConversion of the HIV protease inhibitor nelfinavir to a bioactive metabolite by human liver CYP2C19. _h[electronic resource] |
| 260 |
_bDrug metabolism and disposition: the biological fate of chemicals _cDec 2004 |
||
| 300 |
_a1462-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xpharmacology |
| 650 | 0 | 4 |
_aAryl Hydrocarbon Hydroxylases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 | _aCytochrome P-450 CYP2C19 |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacokinetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydroxylation |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aMicrosomes, Liver _xmetabolism |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNelfinavir _xanalogs & derivatives |
| 650 | 0 | 4 |
_aOmeprazole _xpharmacology |
| 700 | 1 | _aRaucy, Judy L | |
| 700 | 1 | _aLasker, Jerome M | |
| 773 | 0 |
_tDrug metabolism and disposition: the biological fate of chemicals _gvol. 32 _gno. 12 _gp. 1462-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1124/dmd.104.001743 _zAvailable from publisher's website |
| 999 |
_c15140743 _d15140743 |
||